PET/CT in the Imaging of CNS Tumors.

Jolanta Kunikowska, Katarzyna Barańska, Katarzyna Niemas, Kacper Pełka

Journal: Seminars in nuclear medicine 2025;55(4):475-486

PMID: 40404539

Full Text on Elsevier Science View on PubMed

Abstract

Central nervous system (CNS) tumors are quite rare but cause significant morbidity and mortality. Positron Emission Tomography (PET) is a widely utilized imaging modality within the field of nuclear medicine. CNS tumor diagnostics are an essential tool in the diagnosis and treatment of patients with glioma, offering valuable insights into tumor characteristics, treatment response and outcomes. A variety of different tracers are used in PET imaging of brain tumors including F-labeled fluorodeoxyglucose ([F]FDG), markers showing amino acid metabolism, angiogenesis or inflammatory processes. In this article we describe possibility of use different tracers in different clinical scenario of CNS tumors.

Address: Department of Endocrine Oncology and Nuclear Medicine, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Department of Nuclear Medicine, Medical University of Warsaw, Warsaw, Poland.; Department of Nuclear Medicine, Medical University of Warsaw, Warsaw, Poland. Electronic address: [email protected].

DOI: 10.1053/j.semnuclmed.2025.04.002

Link outs

Subscription / membership required

Full Text Sources:

MeSH Terms: Humans, Positron Emission Tomography Computed Tomography, Central Nervous System Neoplasms